ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Chiesi Group Receives European Marketing Authorization for Trimbow? Inhalation Powder americanpharmaceuticalreview
April 22, 2021Chiesi, an international research-focused healthcare group has announced that the European Commission has granted the marketing authorization for Trimbow? inhalation powder delivered through NEXThaler (beclometasone dipropionate, formoterol fumarate ... -
EU approves Chiesi’s triple combination asthma therapy Trimbow pharmatimes
February 02, 2021The European Commission (EC) has approved a marketing authorisation for Chiesi Group’s triple combination asthma therapy Trimbow (beclometasone/formoterol/glycopyrronium).
Pharma Sources Insight January 2025
